Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up.
Haque
Tanzina
T
McAulay
Karen A
KA
Kelly
Deirdre
D
Crawford
Dorothy H
DH
D001782:Blood Donors; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D006680:HLA Antigens / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000276:immunology*; D016377:Organ Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*; D014015:Tissue Banks
D006680:HLA Antigens